<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8A687C00-D817-493C-9419-2520D5C5FEC7"><gtr:id>8A687C00-D817-493C-9419-2520D5C5FEC7</gtr:id><gtr:name> Cukurova University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A2EC0DF1-142D-422A-AB83-724ABEC8BE19"><gtr:id>A2EC0DF1-142D-422A-AB83-724ABEC8BE19</gtr:id><gtr:name>University of the Witwatersrand</gtr:name><gtr:address><gtr:line1>University of the Witwatersrand</gtr:line1><gtr:line2>WITS</gtr:line2><gtr:line3>2050</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A687C00-D817-493C-9419-2520D5C5FEC7"><gtr:id>8A687C00-D817-493C-9419-2520D5C5FEC7</gtr:id><gtr:name> Cukurova University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A2EC0DF1-142D-422A-AB83-724ABEC8BE19"><gtr:id>A2EC0DF1-142D-422A-AB83-724ABEC8BE19</gtr:id><gtr:name>University of the Witwatersrand</gtr:name><gtr:address><gtr:line1>University of the Witwatersrand</gtr:line1><gtr:line2>WITS</gtr:line2><gtr:line3>2050</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A0CBAAE6-12FF-4EE2-A774-DB55503C36F6"><gtr:id>A0CBAAE6-12FF-4EE2-A774-DB55503C36F6</gtr:id><gtr:firstName>RP</gtr:firstName><gtr:surname>Millar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D85C8E73-A711-465B-AF7B-D59710C634A4"><gtr:id>D85C8E73-A711-465B-AF7B-D59710C634A4</gtr:id><gtr:firstName>Zhi-liang</gtr:firstName><gtr:surname>Lu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127685846"><gtr:id>E282E95A-7002-4019-A4DE-071D64687AF7</gtr:id><gtr:title>Molecular/structural basis of ligand-induced selective signalling of G protein-coupled receptors in reproduction/cancers</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127685846</gtr:grantReference><gtr:abstractText>Neuropeptide hormones play important roles in regulation of the mammalian reproductive system. In the pituitary gland, GnRH stimulates release of gonadotropins which in turn regulate sex steroid hormones and production of eggs or sperm. Interestingly, GnRH has a direct inhibitory effect on the growth of cancer cells in reproductive tissues. As a result of its pivotal role, GnRH analogues are widely employed in the treatment of infertility and hormone-dependent diseases. ||GnRH analogues exert their pharmacological effects through binding to a G protein-coupled receptor on cell surfaces. This binding triggers a change of the receptor 3D-structure enabling it to recognise and activate G proteins and their downstream signalling inside of cells and resulting in changes in function, shape or mobility of cells.||We use molecular modelling and site-directed mutagenesis studies to reveal how GnRH analogues bind to the human GnRH receptor and how GnRH binding triggers a change of the receptor 3D-structure and how this change recognises and activates different G proteins and their intracellular signalling. This study will enhance our understanding of the receptor activation mechanisms and identify novel signalling pathways and assist development of novel GnRH analogues with improved pharmacologic specificity and reduced side-effects caused by off-target cross-activity.</gtr:abstractText><gtr:technicalSummary>The gonadotropin-releasing hormone (GnRH) receptor is central to the control of the entire reproductive system and therefore a critical target for therapeutic intervention. Our recent discovery that different GnRH analogues have differential effects on intracellular signalling pathways has major implications. The first is that the human GnRH receptor can assume a number of different active conformations that mediate different signalling pathways. The second is that GnRH ligand binding breaks intramolecular constraint networks and creates new sets of inter- and intra-molecular contacts that stabilise the receptor in different active conformations mediating different signalling. The third is that different GnRH analogues make a number of common and ligand-specific inter-molecular contacts with the receptor that stabilise distinct receptor active conformations which give rise to differential signalling.||Due to the difficulty of crystallising GPCRs, our understanding of ligand-induced receptor conformational changes associated with receptor activation relies on biophysical and biochemical studies. Using molecular modelling, receptor mutagenesis and a range of substituted GnRH analogues, we have made progress in identifying the inter- and intra-molecular contact residues involved in GnRH ligand binding and receptor activation. In this programme, we will use molecular modelling, sequence analysis of co-ordinated evolutionary changes of amino acids among GnRH receptors and naturally occurring hGnRH receptor mutations to identify potential inter- and intra-molecular contact residues. This information will be used for further studies using site-directed mutagenesis and GnRH analogues with single amino acid substitution to define their functions in the receptor conformational switch and consequent signal selectivity.||The GnRH receptor has been proposed to couple with different G proteins to mediate different physiological and pharmacological effects. We are endeavouring to clarify these interactions at molecular and atomic level, and to unravel novel GnRH receptor signalling pathways and the mechanisms of GnRH analogue-stimulated antiproliferative effects on cancer cells. These studies will enhance our understanding of GnRH receptor activation mechanisms and the efficacy and side effects of GnRH analogues currently employed in a diversity of clinical treatments and assist in the development of novel therapeutic signal-selective GnRH analogues which act via receptor conformational selection.||We are also extending our research to other GPCRs such as Kisspeptin/GPR54, GnIH/GPR147 and Estrogen/GPR30 which also play important roles in reproductive health and illness.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1568947</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of the Witwatersrand</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Medical School Witwatersrand</gtr:department><gtr:description>Dr Colleen A. Flanagan</gtr:description><gtr:id>378DEC18-66A8-40A0-8A64-B526BF5C316C</gtr:id><gtr:impact>3</gtr:impact><gtr:outcomeId>75E24CACF95-1</gtr:outcomeId><gtr:partnerContribution>Co-supervision of a PhD student</gtr:partnerContribution><gtr:piContribution>We made main contribution to this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cukurova University</gtr:collaboratingOrganisation><gtr:country>Turkey, Republic of</gtr:country><gtr:department>Division of Paediatric Endocrinology and Metabolism</gtr:department><gtr:description>A. Kemal Topalogu</gtr:description><gtr:id>59768D1F-C785-4838-BA3D-AB204B87D945</gtr:id><gtr:impact>1</gtr:impact><gtr:outcomeId>A580D8065FC-1</gtr:outcomeId><gtr:partnerContribution>Identified a natural mutation of the GnRH receptor in patients.</gtr:partnerContribution><gtr:piContribution>Characterization of the mutant receptor in vitro.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Edward C Hulme</gtr:description><gtr:id>63AC916C-C7A1-4275-9B83-548D2302A712</gtr:id><gtr:impact>1</gtr:impact><gtr:outcomeId>Tsdy9g2oft6-1</gtr:outcomeId><gtr:partnerContribution>experiemntal design and lab work</gtr:partnerContribution><gtr:piContribution>Experimental design, construction of mutants, writing up</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Reproductive Sciences Unit</gtr:department><gtr:description>Gray NK</gtr:description><gtr:id>EDAE7D85-E5A5-4DB6-9B2F-8B88F9DF422B</gtr:id><gtr:impact>1</gtr:impact><gtr:outcomeId>ie9oG7PqbNw-1</gtr:outcomeId><gtr:partnerContribution>1</gtr:partnerContribution><gtr:piContribution>Molecular modelling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Basic Medical Sciences</gtr:department><gtr:description>Katalin Torok</gtr:description><gtr:id>52B54EE7-3736-4316-BD16-0CE70DB91F30</gtr:id><gtr:impact>0</gtr:impact><gtr:outcomeId>TFKZmfwkbfd-1</gtr:outcomeId><gtr:partnerContribution>The collaborator provided us with some research materials and the approach to detect the interactions between GRP54 and calmodulin/CaMKII.</gtr:partnerContribution><gtr:piContribution>We initiated the project regarding the interaction of Kisspeptin receptor (GPR54) with calmodulin and calmodulin kinase II.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Metabolic Science (IMS)</gtr:department><gtr:description>Stephen O'Rahilly</gtr:description><gtr:id>8B67FCC4-1F7F-4FF3-AF29-A296181C4EA3</gtr:id><gtr:impact>1</gtr:impact><gtr:outcomeId>D40A16BC36C-1</gtr:outcomeId><gtr:partnerContribution>Identified a natural mutation of the GnRH receptor in patients.</gtr:partnerContribution><gtr:piContribution>Characterization of the mutant receptor in vitro.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Annual Meeting of the Endocrine Scoiety, USA</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>AB6E9EA4-4D76-41E3-BF81-7970265D18FC</gtr:id><gtr:impact>Research conference

To present the work carried out at the MRC HRSU.</gtr:impact><gtr:outcomeId>A58EE5E3311</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British pharmacological society summer meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>A7C4FD0D-F407-4865-B98B-87A9D138523D</gtr:id><gtr:impact>Invited talk at the BPS summer meeting

Symposium lecture</gtr:impact><gtr:outcomeId>70FF3393183</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BioScience</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>CCFD71C4-2878-4416-8457-3C8E23D1EE0F</gtr:id><gtr:impact>Research conference

To present reaesrch work carried out at the MRC HRSU.</gtr:impact><gtr:outcomeId>53B1184F7B5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gordon Research Conference in Molecular Pharmacology</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>22EE44F7-049E-4561-BC13-DCF0BAAD5C87</gtr:id><gtr:impact>GRC are prestigious conferecenes to discuss research progress within a specific area.

To present the work carried out at the MRC Unit.</gtr:impact><gtr:outcomeId>31CBF12616F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visiting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>0C52B033-C2D4-49A8-BFC2-F7CDE01C0116</gtr:id><gtr:impact>About 30 researchers and students attended the talk

Scientific inspiration</gtr:impact><gtr:outcomeId>FGoceRT3koF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminars at MRC LMB and NIMR</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>266D3BD2-98BF-42EA-9A76-38066FB6BC64</gtr:id><gtr:impact>Invited talks at MRC LMB and NIMR.

For potential collaboration.</gtr:impact><gtr:outcomeId>3DBD470D966</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>9th International Symposium on GnRH: The Hypothalamic-Pituitary-Gonadal Axis in Cancer and Reproduction</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>E7E9A4F9-FB0B-47A7-AA2B-9D0F084BAF96</gtr:id><gtr:impact>This symposium brought basic resreacher, clinician and clinic researcher, chemists and pharmacologists around the world under one roof to discuss progress made on GnRH and potential collaboration.

Invited talk.</gtr:impact><gtr:outcomeId>965099BB8CE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have built models of the human GnRH receptor in inactive and active conformational states which were refined using extensive site-directed mutagensis results obtained in our own and other labs.</gtr:description><gtr:id>6D9DAB0A-8BE1-4FE2-A0F7-5094026F3688</gtr:id><gtr:impact>About 50% of clinical drugs target G protein-coupled recpetors (GPCRs), but only a few 3-dimensional structures of GPCRs have been available. We aim to build reliabe GnRH receptor models which could be used for in-silico screening of ligands. If success, this can be extended to other GPCRs.</gtr:impact><gtr:outcomeId>EB412DC32AD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GnRH receptor models</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Molecular modelling</gtr:description><gtr:id>38C62EE2-0E23-4E0A-8D86-38D32C2E0A44</gtr:id><gtr:impact>to predict the potential interactions of kisspeptin with its receptor which can be tested by mutagenesis studies and assist in development of novel kisspeptin analogues.</gtr:impact><gtr:outcomeId>K6NWinAWfSd</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Molecular Models of Kisspeptin and GPR54</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>38B0691A-BABA-4E3E-9EDA-5AF4873E1DE0</gtr:id><gtr:title>Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55d52fb35920fa70c7b4ab54514a6e57"><gtr:id>55d52fb35920fa70c7b4ab54514a6e57</gtr:id><gtr:otherNames>Forfar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>NMC1MB3oiMG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C4F3D3B-8D89-44E6-B4AC-54447333F341</gtr:id><gtr:title>A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0254dbc190faccb715829795816143ac"><gtr:id>0254dbc190faccb715829795816143ac</gtr:id><gtr:otherNames>White CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>C08368DCBC1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>576137B3-BBDA-467A-B54F-88D74F8C41DE</gtr:id><gtr:title>Gonadotropin-releasing hormone receptors.</gtr:title><gtr:parentPublicationTitle>Endocrine reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d30c01de2bf5e02d1364c0fd0e2ba03d"><gtr:id>d30c01de2bf5e02d1364c0fd0e2ba03d</gtr:id><gtr:otherNames>Millar RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0163-769X</gtr:issn><gtr:outcomeId>pm_15838_18_15082521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2D7A230-823A-4ACC-B2D2-55E44C49BDBF</gtr:id><gtr:title>Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c2642d06f2ea4a0916d73809dcae654"><gtr:id>7c2642d06f2ea4a0916d73809dcae654</gtr:id><gtr:otherNames>Kaye RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>ACPweaUxz8g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>468CB860-8B4F-414B-951D-FCAA944830E6</gtr:id><gtr:title>Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84cbccc188f0530d95a8967a68afd913"><gtr:id>84cbccc188f0530d95a8967a68afd913</gtr:id><gtr:otherNames>Lu ZL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>579D1C994CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>695A66A4-7266-4D0B-BB7B-AA031C947774</gtr:id><gtr:title>Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac938ec0dd9ea375263180f8739772e"><gtr:id>cac938ec0dd9ea375263180f8739772e</gtr:id><gtr:otherNames>L?pez de Maturana R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>6CE599EB085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C401D24E-D98D-44CB-B9B1-3FC2240DC1F3</gtr:id><gtr:title>The multifunctional poly(A)-binding protein (PABP) 1 is subject to extensive dynamic post-translational modification, which molecular modelling suggests plays an important role in co-ordinating its activities.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>bXKgSyP1jju</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EA2FADD-7199-491D-9051-FC3F7DC304C6</gtr:id><gtr:title>Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06d8982d1e7fa6e2a027a7997920648"><gtr:id>a06d8982d1e7fa6e2a027a7997920648</gtr:id><gtr:otherNames>Topaloglu AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>3B166774C31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD68947E-6457-4987-BD48-096C597AAA0D</gtr:id><gtr:title>Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72cc5081dc59a73d752576c51bbc909a"><gtr:id>72cc5081dc59a73d752576c51bbc909a</gtr:id><gtr:otherNames>Coetsee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5E63666AEF0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C808C3E-3E40-4CE9-9AFF-EF37DED72838</gtr:id><gtr:title>Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84cbccc188f0530d95a8967a68afd913"><gtr:id>84cbccc188f0530d95a8967a68afd913</gtr:id><gtr:otherNames>Lu ZL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15838_18_15967801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AF3FAE0-5A19-4F7A-A6DC-99E53E239035</gtr:id><gtr:title>Mammalian type I gonadotropin-releasing hormone receptors undergo slow, constitutive, agonist-independent internalization.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a2b7dd178f2a3f4ada7a2b6f2289e04"><gtr:id>3a2b7dd178f2a3f4ada7a2b6f2289e04</gtr:id><gtr:otherNames>Pawson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>82856D881D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC1C08EC-C2FF-4A52-ACF8-BEC74EE96687</gtr:id><gtr:title>Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88847d7f0875c22c6a9b37e4f5b16cda"><gtr:id>88847d7f0875c22c6a9b37e4f5b16cda</gtr:id><gtr:otherNames>Barran PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15838_18_16157590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C145BF-0D4E-4B2A-924E-824CBA2CC3C1</gtr:id><gtr:title>Conserved amino acid residues that are important for ligand binding in the type I gonadotropin-releasing hormone (GnRH) receptor are required for high potency of GnRH II at the type II GnRH receptor.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c35d29813ef3fe887ee73fa46e41af64"><gtr:id>c35d29813ef3fe887ee73fa46e41af64</gtr:id><gtr:otherNames>Mamputha S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>8D2FEEC41C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3E97F64-5E24-4267-B373-7786B8DBCD30</gtr:id><gtr:title>Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60fe7763581fe9d8ccb7b6d64afc8242"><gtr:id>60fe7763581fe9d8ccb7b6d64afc8242</gtr:id><gtr:otherNames>Stewart AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>782B6145D1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAC011A0-FAA2-49DE-96E9-7B4F4B17ABF8</gtr:id><gtr:title>Bovine and ovine gonadotropin-releasing hormone (GnRH)-II ligand precursors and type II GnRH receptor genes are functionally inactivated.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de45de8bb44d401206ad3a7925ec7449"><gtr:id>de45de8bb44d401206ad3a7925ec7449</gtr:id><gtr:otherNames>Morgan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>1E9D3ED7F29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93D6C874-A371-4B23-B604-DEFFA90309CE</gtr:id><gtr:title>Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapy.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0254dbc190faccb715829795816143ac"><gtr:id>0254dbc190faccb715829795816143ac</gtr:id><gtr:otherNames>White CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>475E3DC0B43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22E0F6DB-45AF-48B3-9570-F18D84BFBDB8</gtr:id><gtr:title>Diversity of actions of GnRHs mediated by ligand-induced selective signaling.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d30c01de2bf5e02d1364c0fd0e2ba03d"><gtr:id>d30c01de2bf5e02d1364c0fd0e2ba03d</gtr:id><gtr:otherNames>Millar RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0091-3022</gtr:issn><gtr:outcomeId>8E6CD548A9E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127685846</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>